It recommends healthcare practitioners should offer a low-dose combination of inhaled corticosteroids (ICS) and formoterol to be taken as needed for everyone aged 12 and over with newly diagnosed ...

These sections briefly explain why the committee made the recommendations and how they might affect practice. As this guideline applies to England and Scotland, the perspective was for both England ...

We will update the guideline on asthma.

Reason for decision Anticipate the topic will be of importance to patients, carers, professionals, commissioners and the health of the public to ensure clinical benefit is realised, inequalities in ...

To find BTS, NICE or SIGN guidance on related topics, including guidance in development, see the BTS guidelines, the NICE topic page on asthma and the SIGN guidelines. For full details of the evidence ...

See recommendations on pharmacological management in people aged 12 and over and the summary of pharmacological management in people aged 12 years and over in the BTS, NICE and SIGN guideline on ...

See recommendations on initial clinical assessment in the BTS, NICE and SIGN guideline on asthma. See also, the tables on alternative diagnoses in wheezy children and alternative diagnoses in adults ...

The highly specialised technologies evaluation committee is a standing advisory committee of NICE. This topic was considered by the chair and vice chair of this committee. Committee members are asked ...

This indicator covers the percentage of patients with cardiovascular disease in whom the last recorded LDL or non-HDL cholesterol level (measured in the preceding 12 months) is 2.0 mmol per litre or ...

See recommendations on asthma in pregnancy and breastfeeding in the BTS, NICE and SIGN guideline on asthma. For recommendations on intrapartum care, see the NICE guideline on intrapartum care for ...